Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI). [electronic resource]
Producer: 20180507Description: 3824-3830 p. digitalISSN:- 1643-3750
- Adenosine -- analogs & derivatives
- Aged
- Blood Platelets -- drug effects
- Clopidogrel
- Coronary Disease -- drug therapy
- Cytochrome P-450 CYP2C19 -- genetics
- Cytochrome P-450 CYP2C19 Inhibitors -- pharmacology
- Drug Therapy, Combination
- Drugs, Chinese Herbal -- therapeutic use
- Female
- Humans
- Male
- Middle Aged
- Mutation
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Ticagrelor
- Ticlopidine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.